Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $150.6750 (-8.4%) ($150.6750 - $150.6750) on Tue. Mar. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.22% (three month average) | RSI | 54 | Latest Price | $150.6750(-8.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.5% a day on average for past five trading days. | Weekly Trend | LGND advances 4.5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(58%) IWM(55%) IWC(53%) XBI(53%) | Factors Impacting LGND price | LGND will decline at least -2.61% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.61% (StdDev 5.22%) | Hourly BBV | -2.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $154.11 | 5 Day Moving Average | $159.9(-5.77%) | 10 Day Moving Average | $159.5(-5.53%) | 20 Day Moving Average | $154.11(-2.23%) | To recent high | -30.2% | To recent low | 52.6% | Market Cap | $2.421b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |